From the *Department of Anesthesiology and Pain Medicine, Malignant Hyperthermia Investigation Unit, Toronto General Hospital–University Health Network, Toronto, Ontario, Canada
†Department of Paediatric Neurology, Neuromuscular Service, Evelina Children’s Hospital, Guy’s and St Thomas’ Hospital NHS Foundation Trust, London, United Kingdom
‡Randall Centre for Cell and Molecular Biophysics, Muscle Signalling Section, Faculty of Life Sciences and Medicine, King’s College, London, United Kingdom
§Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands.
Accepted for publication July 21, 2022.
Published online 6 October 2022.
The authors declare no conflicts of interest.
Address correspondence to Sheila Riazi, MSc, MD, Toronto General Hospital, Malignant Hyperthermia Investigation Unit, 323-200 Elizabeth St, Toronto, ON M5G 2C4, Canada. Address e-mail to [email protected].